Education
About Us
Working with TipRanks
Follow Us
Lytix Biopharma AS (DE:6BG)
:6BG
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 11.13M | kr 3.99M | kr 11.03M | kr 19.31M | kr 3.00K |
| Gross Profit | kr -23.46M | kr 3.99M | kr 11.03M | kr 19.31M | kr 3.00K |
| Operating Income | kr -95.90M | kr -96.78M | kr -65.67M | kr -47.98M | kr -42.37M |
| EBITDA | kr -93.22M | kr -86.88M | kr -54.91M | kr -47.56M | kr -42.09M |
| Net Income | kr -94.27M | kr -87.90M | kr -56.07M | kr -48.08M | kr -42.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 130.79M | kr 48.98M | kr 143.78M | kr 197.28M | kr 28.45M |
| Total Assets | kr 146.53M | kr 63.87M | kr 153.27M | kr 202.96M | kr 32.62M |
| Total Debt | kr 2.64M | kr 492.00K | kr 1.34M | kr 0.00 | kr 0.00 |
| Net Debt | kr -128.15M | kr -25.30M | kr -91.83M | kr -197.28M | kr -28.45M |
| Total Liabilities | kr 38.64M | kr 12.55M | kr 18.23M | kr 13.34M | kr 12.73M |
| Stockholders' Equity | kr 107.89M | kr 51.32M | kr 135.03M | kr 189.62M | kr 19.89M |
| Cash Flow | |||||
| Free Cash Flow | kr -70.37M | kr -96.02M | kr -52.78M | kr -44.61M | kr -24.35M |
| Operating Cash Flow | kr -70.37M | kr -95.97M | kr -52.63M | kr -44.61M | kr -24.35M |
| Investing Cash Flow | kr 24.69M | kr 29.73M | kr -49.35M | kr 138.00K | kr 0.00 |
| Financing Cash Flow | kr 149.10M | kr -943.00K | kr -749.00K | kr 213.30M | kr 40.00M |
Lytix Biopharma AS Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.